AC Immune S.A.

AC Immune S.A.verified

ACIU

Price:

$3.015

Market Cap:

$239.74M

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD). It is also developing ACI-24, an anti-Abeta vaccine candidate that is ...[Read more]

Industry

Biotechnology

IPO Date

2016-09-23

Stock Exchange

NASDAQ

Ticker

ACIU

The Enterprise Value as of March 2026 (TTM) for AC Immune S.A. (ACIU) is 217.46M

According to AC Immune S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 217.46M. This represents a change of 19.69% compared to the average of 181.68M of the last 4 quarters.

AC Immune S.A. (ACIU) Historical Enterprise Value (quarterly & annually)

How has ACIU Enterprise Value performed in the past?

The mean historical Enterprise Value of AC Immune S.A. over the last ten years is 321.90M. The current 217.46M Enterprise Value has changed 6.66% with respect to the historical average. Over the past ten years (40 quarters), ACIU's Enterprise Value was at its highest in in the March 2016 quarter at 766.17M. The Enterprise Value was at its lowest in in the March 2023 quarter at 125.38M.

Quarterly (TTM)
Annual

Average

321.90M

Median

269.99M

Minimum

128.74M

Maximum

618.07M

AC Immune S.A. (ACIU) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AC Immune S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 118.31%

Maximum Annual Enterprise Value = 618.07M

Minimum Annual Increase = -56.40%

Minimum Annual Enterprise Value = 128.74M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025228.64M7.10%
2024213.49M-24.04%
2023281.04M118.31%
2022128.74M-50.28%
2021258.93M51.85%
2020170.52M-56.40%
2019391.09M-6.66%
2018418.99M-32.21%
2017618.07M21.31%
2016509.49M-35.55%

AC Immune S.A. (ACIU) Average Enterprise Value

How has ACIU Enterprise Value performed in the past?

The current Enterprise Value of AC Immune S.A. (ACIU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

241.06M

5-year avg

222.17M

10-year avg

321.90M

AC Immune S.A. (ACIU) Enterprise Value vs. Peers

How is ACIU’s Enterprise Value compared to its peers?

AC Immune S.A.’s Enterprise Value is greater than Aldeyra Therapeutics, Inc. (-54510836746024.00), less than Cellectis S.A. (301.02M), less than Alto Neuroscience, Inc. (581.24M), less than Silence Therapeutics plc (314.48M), greater than Amarin Corporation plc (194.57M), less than Contineum Therapeutics, Inc. Class A Common Stock (407.53M), less than Lyell Immunopharma, Inc. (433.17M), greater than Mereo BioPharma Group plc (13.33M), less than Annexon, Inc. (564.43M), less than Alpha Tau Medical Ltd. (609.09M),

Build a custom stock screener for AC Immune S.A. (ACIU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AC Immune S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AC Immune S.A. (ACIU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AC Immune S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AC Immune S.A.'s Enterprise Value?

What is the highest Enterprise Value for AC Immune S.A. (ACIU)?

What is the 3-year average Enterprise Value for AC Immune S.A. (ACIU)?

What is the 5-year average Enterprise Value for AC Immune S.A. (ACIU)?

How does the current Enterprise Value for AC Immune S.A. (ACIU) compare to its historical average?